Daily Market Comment – Markets sink despite Fed tranquilizer



  • Stocks suffer, dollar shines amid whispers of hedge fund slaughter
  • Fed plays down tapering speculation, but unable to calm nerves
  • Euro on the ropes as ECB rate cut speculation returns
  • US GDP data coming up today amid peculiar earnings season

Short squeeze epidemic forces hedge fund liquidations

The sound you are listening to is the stock market cracking from within, as a few funds liquidate their books to cover losses on their short bets, which retail traders have pushed to the moon. Or at least, this is the popular narrative.

A coordinated army of retail traders has weaponized call options contracts lately to engineer some epic short squeezes in heavily shorted small cap stocks. Options have embedded leverage, so if small investors bet a stock will soar this way, they can push the price much higher as the market makers selling those options to them are forced to hedge their exposure, by buying the underlying asset too.

It is essentially a feedback loop, where buying bullish options forces big dealers to buy the stock as well, sending the price higher and leading short sellers to cover or close their positions to avoid bigger losses, adding more fuel to the rally. A few funds were apparently caught on the wrong side of this dynamic, sparking a selloff in the broader market as they liquidated long positions to cover their short losses. Some others may be simply de-leveraging.

The S&P 500 fell by almost 2.6% and futures point to another 1% loss at the open today.

Dollar shines despite dovish Fed

Even the Fed chief couldn’t calm investors’ nerves yesterday, despite being as dovish as he possibly could. He rejected the idea that the Fed will scale back its colossal QE program anytime soon, which normally would be great news for risky assets and bad news for the dollar, but investors had other things on their mind.

The dollar outperformed as traders looked for some insurance against a deeper correction in equity markets, though the reserve currency also capitalized on some weakness in the euro.

The fragility of the Eurozone economy has come back under the microscope, with the shortage of vaccines cementing fears that a double-dip recession is inevitable. Meanwhile, the ECB is actively trying to keep a lid on the exchange rate. Some policymakers have warned that another rate cut is possible, while others advocate for a Fed-style inflation overshoot regime, either of which would damage the euro.

Overall, it is difficult to find reasons to be optimistic on the euro nowadays. A slow vaccine rollout, an anemic recovery, and the lack of any impressive fiscal stimulus paint a stark contrast to America. The narrative of economic divergence could ultimately dominate, keeping the risks around euro/dollar tilted to the downside.

US GDP numbers and more earnings coming up

As for today, the preliminary estimate of US GDP for Q4 will be in focus. Forecasts suggest a 4% annualized increase, but the Atlanta Fed GDPNow model points to a 7.2% print, so there might be scope for an upside surprise.

The barrage of earnings will continue with McDonalds, Visa, and Mastercard. A worrisome pattern has emerged lately where market heavyweights beat their earnings forecasts, but their stock barely rises or even falls. Microsoft, Apple, and Facebook have all suffered the same fate this week. It could be a signal that too much good news was already baked in at these stratospheric valuations, and that investors are happy to take profits instead of reloading here.

Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.

All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.

Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.

We are using cookies to give you the best experience on our website. Read more or change your cookie settings.

Risk Warning: Your capital is at risk. Leveraged products may not be suitable for everyone. Please consider our Risk Disclosure.